Medical Condition News

RSS

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Houtan Noushmehr, Ph.D., a researcher at Henry Ford Health, has been awarded a prestigious R01 grant of nearly $2.9M from the National Institutes of Health (NIH) to support a research project titled, "Circulating cell-free DNA methylation as an accurate tool for detection and clinical follow-up of glioma."

27 Jul 2023

Embracing nature's medicine: exploring medicinal plants for diabetes treatment

Researchers described 20 medicinal plants, their bioactive phytochemical components, therapeutic potential, modes of action, and prospects and ability to combat diabetes mellitus.

27 Jul 2023

The role of diet in the management of retinal vein occlusion

Researchers investigate the potential impact of dietary habits on retinal vein occlusion.

27 Jul 2023

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study investigated if patients with systemic autoimmune rheumatic diseases (SARDs) have a reduced immunological response.

27 Jul 2023

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.

27 Jul 2023

Recent progress in infant hepatitis B vaccination efforts in Africa

Researchers report advancements made toward the elimination of mother-to-child transmission of hepatitis B infection.

27 Jul 2023

Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

Researchers measured the association between reproduction number, a weekly measure of real-time severe acute respiratory syndrome coronavirus 2.

27 Jul 2023

The role of vasomotor reactivity in COVID-19 patients

Researchers searched and collated the most relevant published literature on cerebral hemodynamic changes in COVID-19 patients.

27 Jul 2023

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present in roughly seven percent of middle-aged adults, less than one percent of BE patients will progress to EAC, making it difficult to determine which individuals are at risk of developing this deadly cancer.

27 Jul 2023

People with Alzheimer's risk gene may lose ability to detect odors earlier

People who carry the gene variant associated with the strongest risk for Alzheimer's disease may lose their ability to detect odors earlier than people who do not carry the gene variant, which may be an early sign of future memory and thinking problems, according to a study published in the July 26, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Jul 2023

Experts weigh benefits and risks of new Alzheimer's disease therapies

New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease.

26 Jul 2023

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer's disease and concerns about episodes of memory decline, according to a UCLA Health study.

26 Jul 2023

Two infusions of IL-15-expressing CAR NK Cells boost survival in lymphoma mouse models

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered loss of metabolic fitness in chimeric antigen receptor (CAR) natural killer (NK) cells is a critical mechanism of resistance, with infused cells gradually losing the ability to compete with tumor cells for nutrients, leading to tumor relapse.

26 Jul 2023

More steps linked to improved health for heart failure patients

KIAA0930 could be a novel therapeutic target for cancer cachexia

A new research paper was published in Oncotarget's Volume 14 on July 20, 2023, entitled, "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."

26 Jul 2023

Hypnosis offers new hope for people with spinal cord injury pain

Hypnosis was effective in helping people with recent spinal cord injuries learn coping strategies to fight chronic pain, a new study shows. Almost 90% of participants reported benefit from the treatment.

26 Jul 2023

Core promoter variation may drive development of triple-negative breast cancer

TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

26 Jul 2023

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other types of cardiovascular disease (CVD).

26 Jul 2023

Researchers discover potential new treatment for rhabdomyosarcoma

Researchers from the Leibniz Institute on Aging in Jena and the Brandenburg University of Technology Cottbus-Senftenberg have discovered a novel treatment approach for soft tissue tumors, which are frequently occurring in children and are often malignant.

26 Jul 2023

$Epileptika aims to help treat refractory epilepsy in people with intellectual disability$

Epileptika aims to help treat refractory epilepsy in people with intellectual disability

A team of researchers from the Universitat Politècnica de València (UPV) has participated in the development of Epileptika.

26 Jul 2023

Medical Condition News

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Embracing nature's medicine: exploring medicinal plants for diabetes treatment

The role of diet in the management of retinal vein occlusion

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

Recent progress in infant hepatitis B vaccination efforts in Africa

Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

The role of vasomotor reactivity in COVID-19 patients

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

People with Alzheimer's risk gene may lose ability to detect odors earlier

Experts weigh benefits and risks of new Alzheimer's disease therapies

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Two infusions of IL-15-expressing CAR NK Cells boost survival in lymphoma mouse models

More steps linked to improved health for heart failure patients

KIAA0930 could be a novel therapeutic target for cancer cachexia

Hypnosis offers new hope for people with spinal cord injury pain

Core promoter variation may drive development of triple-negative breast cancer

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

Researchers discover potential new treatment for rhabdomyosarcoma

Epileptika aims to help treat refractory epilepsy in people with intellectual disability

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News